# FDA Inspection 1070920 - Corden Pharma Bergamo SPA - September 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/corden-pharma-bergamo-spa/cd22e110-81c9-47a8-9e70-60e3aadf1c12
Source feed: FDA_Inspections

> FDA Inspection 1070920 for Corden Pharma Bergamo SPA on September 27, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070920
- Company Name: Corden Pharma Bergamo SPA
- Inspection Date: 2018-09-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1244028 - 2024-06-26](https://www.keypedia.com/records/fda_inspections/corden-pharma-bergamo-spa/947cb4ca-f26b-4af8-9822-bd7c09bd628b)
- [FDA Inspection 1208591 - 2022-03-18](https://www.keypedia.com/records/fda_inspections/corden-pharma-bergamo-spa/5c6eb21a-a311-4c1c-90c9-d95df09272d6)
- [FDA Inspection 990465 - 2016-06-17](https://www.keypedia.com/records/fda_inspections/corden-pharma-bergamo-spa/99b29c3a-6983-4f10-b65e-99710eec87e2)
- [FDA Inspection 856392 - 2013-11-08](https://www.keypedia.com/records/fda_inspections/corden-pharma-bergamo-spa/6a5061fe-a572-476f-82a3-fe14beb8071d)

Company: https://www.keypedia.com/companies/corden-pharma-bergamo-spa/8f926414-d5ef-49c4-be33-d7c81dfc55ea

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c